Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Gastroenterology · Erosive Esophagitis

Treating and Healing Esophageal Damage

At a Glance

Erosive esophagitis is typically treated with an 8-week course of acid-suppressing medication, such as a PPI or a newer PCAB like vonoprazan. Healing the esophagus also requires key lifestyle changes, including weight management and elevating the head of the bed.

Managing erosive esophagitis (EE) is focused on one primary goal: suppressing stomach acid long enough and consistently enough to allow the damaged lining of your esophagus to heal [1][2].

Standard medical protocols typically involve an initial 8-week course of acid-suppressing medication [1]. Your treatment path often depends on whether your case is “mild” (LA Grade A or B) or “severe” (LA Grade C or D) [3].

First-Line Therapy: Proton Pump Inhibitors (PPIs)

For decades, Proton Pump Inhibitors (PPIs)—such as omeprazole, lansoprazole, and esomeprazole—have been the standard first-line treatment [2].

  • How They Work: PPIs shut down the “pumps” in your stomach cells that produce acid.
  • The “30-Minute” Rule: Traditional PPIs work best when taken 30 to 60 minutes before your first meal of the day, as they need the pumps to be active to work effectively [4].
  • Slow Onset: It can take 3 to 5 days of consistent dosing for a PPI to reach its maximum acid-blocking potential [5].

A New Class of Treatment: PCABs

A newer class of medication called Potassium-Competitive Acid Blockers (PCABs), with vonoprazan being the most common, is changing the way doctors treat EE [6].

  • Faster Action: Unlike PPIs, PCABs reach full strength starting with the very first dose and provide potent, 24-hour acid suppression [7][4].
  • Superior Healing for Severe Cases: Research shows that PCABs are often superior to traditional PPIs for healing and maintaining the esophagus in patients with severe LA Grade C or D disease [8][9].
  • Refractory Cases: If your symptoms do not improve on a standard PPI (called refractory GERD), your doctor may suggest switching to a PCAB [10][11].

Step-Up vs. Step-Down Strategies

Doctors use two main strategies to find the right dose for you:

  1. Step-Up Therapy: Starting with a lower dose or a less potent medication and increasing it only if symptoms persist. This is often used for mild cases [12].
  2. Step-Down Therapy: Starting with a high-potency dose (like a double-dose PPI or a PCAB) to ensure rapid healing, then “stepping down” to the lowest dose that keeps symptoms away once healing is confirmed [2][12].

Essential Lifestyle Interventions

Medication is most effective when paired with evidence-based lifestyle changes recommended by organizations like the American College of Gastroenterology (ACG) [13]:

  • Weight Management: If you are overweight, losing weight is one of the most effective ways to reduce acid exposure and promote long-term healing [14][15].
  • Nocturnal Reflux: If you suffer from symptoms at night, elevating the head of your bed (using a wedge pillow or bed risers) and avoiding meals within 3 hours of bedtime can significantly reduce damage [14][16].
  • Avoid Triggers: Smoking cessation and reducing alcohol intake are also strongly associated with better healing outcomes [17][18].

For those with severe disease (Grade C/D), a follow-up endoscopy is usually recommended after the initial treatment period to confirm that “mucosal resolution” (complete healing) has occurred before reducing medication [19][20].

Back to Home

Common questions in this guide

When should I take my proton pump inhibitor (PPI)?
Traditional PPIs work best when taken 30 to 60 minutes before your first meal of the day. This timing ensures the acid pumps in your stomach are active so the medication can effectively block acid production.
What is the difference between a PPI and a PCAB for esophagitis?
While both block stomach acid, PCABs like vonoprazan work much faster, reaching full strength with the very first dose. PCABs are often more effective for healing severe esophageal damage or cases that do not respond well to standard PPIs.
What does step-down therapy mean for esophageal healing?
Step-down therapy involves starting with a strong dose of acid-blocking medication to rapidly heal the esophagus. Once healing is confirmed, your doctor gradually lowers the dose to the minimum amount needed to keep symptoms away.
How can I stop acid reflux at night?
You can significantly reduce nighttime reflux by elevating the head of your bed with a wedge pillow or bed risers. Additionally, it is highly recommended to avoid eating any meals or snacks within three hours of going to sleep.
Will I need another endoscopy after starting treatment?
If you have severe esophageal damage, such as LA Grade C or D, your doctor will likely recommend a follow-up endoscopy. This procedure confirms the erosions have completely healed before they reduce your medication dose.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my LA Grade, should I start with a standard PPI or would a PCAB like vonoprazan be more effective for initial healing?
  2. 2.If we start with a higher dose of medication (step-down therapy), when can we try to reduce it to the lowest effective dose?
  3. 3.What is our plan if my symptoms don't improve after the first 8 weeks of treatment?
  4. 4.Do I need a follow-up endoscopy to confirm the erosions have completely healed before we change my medication dose?
  5. 5.Which lifestyle changes, specifically for weight management or nocturnal reflux, should I prioritize based on my situation?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Will Heartburn Worsen After Stopping a PPI for Esophagitis?What Diet Helps Erosive Esophagitis Heal With Treatment?How Long Does Erosive Esophagitis Take to Heal on PPIs?Is Vonoprazan Better Than a PPI for Severe Esophagitis?

References

References (20)
  1. 1

    Potassium-competitive acid blockers and proton-pump inhibitors for healing of erosive esophagitis: a systematic review and network meta-analysis.

    Liu Y, Gao Z, Hou X

    Therapeutic advances in gastroenterology 2024; (17()):17562848241251567 doi:10.1177/17562848241251567.

    PMID: 38903448
  2. 2

    Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021.

    Iwakiri K, Fujiwara Y, Manabe N, et al.

    Journal of gastroenterology 2022; (57(4)):267-285 doi:10.1007/s00535-022-01861-z.

    PMID: 35226174
  3. 3

    Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

    Iwakiri K, Kinoshita Y, Habu Y, et al.

    Journal of gastroenterology 2016; (51(8)):751-67 doi:10.1007/s00535-016-1227-8.

    PMID: 27325300
  4. 4

    Pharmacodynamics and Pharmacokinetics of the Potassium-Competitive Acid Blocker Vonoprazan and the Proton Pump Inhibitor Lansoprazole in US Subjects.

    Laine L, Sharma P, Mulford DJ, et al.

    The American journal of gastroenterology 2022; (117(7)):1158-1161 doi:10.14309/ajg.0000000000001735.

    PMID: 35294415
  5. 5

    The binding selectivity of vonoprazan (TAK-438) to the gastric H+, K+ -ATPase.

    Scott DR, Munson KB, Marcus EA, et al.

    Alimentary pharmacology & therapeutics 2015; (42(11-12)):1315-26 doi:10.1111/apt.13414.

    PMID: 26423447
  6. 6

    [Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders].

    Cho MY, Cho YK

    The Korean journal of helicobacter and upper gastrointestinal research 2023; (23(3)):167-173 doi:10.7704/kjhugr.2023.0043.

    PMID: 40502664
  7. 7

    Vonoprazan in Management of Refractory Gastroesophageal Reflux Disease: An Indian Expert Group Consensus Statements.

    Abraham P, Choudhuri G, Deshmukh S, et al.

    The Journal of the Association of Physicians of India 2025; (73(3)):e29-e36 doi:10.59556/japi.73.0878.

    PMID: 40087940
  8. 8

    Efficacy and Safety of Potassium-competitive Acid Blockers Versus Proton Pump Inhibitors in Treating Erosive Esophagitis: A Meta-analysis Based on Randomized Controlled Trials.

    Fang Y, Lou D, Zhou J, et al.

    Journal of clinical gastroenterology 2024; (58(9)):841-850 doi:10.1097/MCG.0000000000002052.

    PMID: 39083496
  9. 9

    Comparative Efficacy of P-CAB vs Proton Pump Inhibitors for Grade C/D Esophagitis: A Systematic Review and Network Meta-analysis.

    Zhuang Q, Chen S, Zhou X, et al.

    The American journal of gastroenterology 2024; (119(5)):803-813 doi:10.14309/ajg.0000000000002714.

    PMID: 38345252
  10. 10

    Dose and duration shape the efficacy of vonoprazan versus lansoprazole for erosive esophagitis: insights from meta-regression.

    Huang PF, Chen HW, Liang YJ

    Therapeutic advances in gastroenterology 2025; (18()):17562848251406098 doi:10.1177/17562848251406098.

    PMID: 41466866
  11. 11

    Use of vonoprazan, a novel potassium-competitive acid blocker, for the treatment of proton pump inhibitor-refractory reflux esophagitis in patients with systemic sclerosis.

    Shirai Y, Kawami N, Iwakiri K, Kuwana M

    Journal of scleroderma and related disorders 2022; (7(1)):57-61 doi:10.1177/23971983211021747.

    PMID: 35386943
  12. 12

    Efficacy of Step-Down Therapy Using Vonoprazan for Symptomatic Mild Reflux Esophagitis.

    Ochiai Y, Kikuchi D, Hoteya S

    Gastroenterology research and practice 2024; (2024()):5620034 doi:10.1155/grp/5620034.

    PMID: 39624644
  13. 13

    ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.

    Katz PO, Dunbar KB, Schnoll-Sussman FH, et al.

    The American journal of gastroenterology 2022; (117(1)):27-56 doi:10.14309/ajg.0000000000001538.

    PMID: 34807007
  14. 14

    Lifestyle Intervention in Gastroesophageal Reflux Disease.

    Ness-Jensen E, Hveem K, El-Serag H, Lagergren J

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2016; (14(2)):175-82.e1-3.

    PMID: 25956834
  15. 15

    Gastroesophageal Reflux Disease: A Review.

    Maret-Ouda J, Markar SR, Lagergren J

    JAMA 2020; (324(24)):2536-2547 doi:10.1001/jama.2020.21360.

    PMID: 33351048
  16. 16

    The role of lifestyle changes in gastroesophageal reflux diseases treatment.

    Dağlı Ü, Kalkan İH

    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2017; (28(Suppl 1)):S33-S37 doi:10.5152/tjg.2017.10.

    PMID: 29199165
  17. 17

    Impact of night-shift work on the prevalence of erosive esophagitis in shipyard male workers.

    Chung TH, Lee J, Kim MC

    International archives of occupational and environmental health 2016; (89(6)):961-6 doi:10.1007/s00420-016-1130-x.

    PMID: 27129469
  18. 18

    Vonoprazan treatment improves gastrointestinal symptoms in patients with gastroesophageal reflux disease.

    Shinozaki S, Osawa H, Hayashi Y, et al.

    The Kaohsiung journal of medical sciences 2017; (33(12)):616-622 doi:10.1016/j.kjms.2017.07.004.

    PMID: 29132551
  19. 19

    Erosive Esophagitis Portends a Benign Clinical Course in the Majority of Patients.

    Bi D, Katzka DA, Lavey CJ, et al.

    Digestive diseases and sciences 2020; (65(11)):3244-3252 doi:10.1007/s10620-019-06027-1.

    PMID: 31907769
  20. 20

    Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.

    Shinozaki S, Osawa H, Kobayashi Y, et al.

    Scandinavian journal of gastroenterology 2018; (53(8)):897-904 doi:10.1080/00365521.2018.1486883.

    PMID: 30056768

This information explains treatment strategies for esophageal damage for educational purposes. It does not replace professional medical advice. Always consult your gastroenterologist to determine the safest and most effective medication for your specific grade of esophagitis.

Get notified when new evidence is published on peptic esophagitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.